Interferon alfa n3 Injection Clinical Trials
- Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects
ClinicalTrials.gov Identifier: NCT00002018 - Completed
HIV Infections
- Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients
ClinicalTrials.gov Identifier: NCT00002012 - Completed
HIV Infections
- A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
ClinicalTrials.gov Identifier: NCT00000844 - Completed
HIV Infections
- Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Allogeneic Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00055874 - Recruiting
chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
- Triple Therapy with Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous HCV Non Responders
ClinicalTrials.gov Identifier: NCT00122629 - Terminated
Hepatitis C, Chronic
- Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection
ClinicalTrials.gov Identifier: NCT00002078 - Completed
HIV Infections
- Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00059826 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Bexarotene and Interferon alfa in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00030849 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; ...
- Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplantation Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00016887 - Active, not recruiting
stage III mantle cell lymphoma; stage IV mantle cell lymphoma
- Combination Chemotherapy Followed By Antiviral Therapy and Interferon alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
ClinicalTrials.gov Identifier: NCT00041327 - Active, not recruiting
stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; stage III adult T-cell leukemia/lymphoma; ...
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy With or Without Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003027 - Active, not recruiting
Stage IV Melanoma
- Combination Chemotherapy, Interferon alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002669 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
primary systemic amyloidosis
- Interferon alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00045422 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
- Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002847 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interferon alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma
ClinicalTrials.gov Identifier: NCT00026416 - Active, not recruiting
stage III adult soft tissue sarcoma; stage IVB adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IIC adult soft tissue sarcoma; ...
- Interferon alfa Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00006249 - Active, not recruiting
stage III melanoma
- Interferon Alfa in Treating Children With HIV-Related Cancer
ClinicalTrials.gov Identifier: NCT00002621 - Active, not recruiting
Leukemia; Lymphoma
- Interferon alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
ClinicalTrials.gov Identifier: NCT00002965 - Active, not recruiting
recurrent adult brain tumor
- Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00015912 - Active, not recruiting
recurrent grade I follicular small cleaved cell lymphoma; recurrent grade II follicular mixed cell lymphoma
- Interferon alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00002882 - Active, not recruiting
stage III melanoma
- Interferon alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053820 - Active, not recruiting
Stage IV Renal Cell Cancer
- Interferon alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00062010 - Active, not recruiting
Recurrent Small Cell Lung Cancer
- Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
ClinicalTrials.gov Identifier: NCT00004196 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- Interferon alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00072046 - Active, not recruiting
Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
- Interferon alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005966 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00004244 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interleukin-2, Interferon alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053807 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
- Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon alfa in Treating Patients With Advanced Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006244 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- PEG-Interferon alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00045279 - Active, not recruiting
Stage IV Renal Cell Cancer
- PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
Stage IV Renal Cell Cancer
- Sorafenib and Interferon alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00098618 - Active, not recruiting
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma; renal granular cell carcinoma
- Temozolomide and Interferon alfa in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00027742 - Active, not recruiting
iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Temozolomide plus PEG-Interferon alfa-2B in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00014261 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00040027 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- Tretinoin Plus Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003656 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00085436 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Bevacizumab With or Without Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026221 - Recruiting
Stage IV Melanoma; Recurrent Melanoma
- Chemotherapy, Interferon alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00068575 - Recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Cisplatin, Gemcitabine, Interferon alfa, and Hyperthermia in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00004063 - Recruiting
unspecified adult solid tumor, protocol specific
- Cisplatin, Metronomic Low-Dose Interferon alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00082862 - Recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- High-Dose Interferon alfa in Treating Patients With Stage II or Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003641 - Recruiting
stage II melanoma; stage III melanoma
- Interferon alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00027664 - Recruiting
Stage IV Renal Cell Cancer
- PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00049530 - Recruiting
Recurrent Melanoma; Stage IV Melanoma
- Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00082719 - Recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- SU011248 or Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00098657 - Recruiting
recurrent renal cell cancer; renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Vaccine Therapy, Interferon alfa, and Cyclophosphamide in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00095862 - Recruiting
recurrent breast cancer; stage IV breast cancer
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
ClinicalTrials.gov Identifier: NCT00134030 - Recruiting
localized osteosarcoma; metastatic osteosarcoma
- Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
ClinicalTrials.gov Identifier: NCT00138151 - Recruiting
recurrent cervical cancer; stage IVB cervical cancer
- Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
ClinicalTrials.gov Identifier: NCT00217373 - Recruiting
unspecified adult solid tumor, protocol specific
- Azacitidine and Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00217542 - Recruiting
Stage III melanoma; Stage IV Melanoma; Stage IV Renal Cell Cancer; recurrent renal cell cancer; Recurrent Melanoma
- Bevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
ClinicalTrials.gov Identifier: NCT00055809 - Completed
recurrent gastrointestinal carcinoid tumor; metastatic gastrointestinal carcinoid tumor; regional gastrointestinal carcinoid tumor
- Combination Chemotherapy and Interferon alfa in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002598 - Completed
relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; atypical chronic myeloid leukemia
- Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon alfa in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00005987 - Completed
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors
ClinicalTrials.gov Identifier: NCT00002470 - Completed
metastatic gastrointestinal carcinoid tumor; recurrent gastrointestinal carcinoid tumor; pulmonary carcinoid tumor
- Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00015847 - Completed
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Interferon alfa and Thalidomide in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00026520 - Completed
Stage IV Melanoma; Recurrent Melanoma
- Interferon alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003007 - Completed
stage III multiple myeloma; refractory plasma cell neoplasm
- A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000725 - Completed
Sarcoma, Kaposi; HIV Infections
- Sorafenib and Interferon alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov Identifier: NCT00101114 - Completed
stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
- A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00001113 - Completed
Sarcoma, Kaposi; HIV Infections
- SU5416 and Interferon alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00006384 - Completed
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Thalidomide Plus Interferon alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed
ClinicalTrials.gov Identifier: NCT00006006 - Completed
localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
- A Randomized Phase II Study of Two Doses of Interferon alfa-2a (IFN alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
ClinicalTrials.gov Identifier: NCT00000754 - Completed
HIV Infections
- PEG-Interferon alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00085384 - Suspended
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002771 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00002475 - Active, not recruiting
Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; pleura cancer
- Thymosin Plus PEG-Interferon in Hepatitis C Patients with Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00039962 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- Advanced Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00065468 - Active, not recruiting
Carcinoma, Renal Cell; Kidney Neoplasms
- Chemotherapy Plus Interferon alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003152 - Active, not recruiting
stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
- Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
localized malignant mesothelioma
- Combination Chemotherapy and Interferon alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00004897 - Active, not recruiting
squamous cell carcinoma of the esophagus; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
- Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
ClinicalTrials.gov Identifier: NCT00019474 - Active, not recruiting
Pancreatic Cancer; Gastric Cancer; adult primary liver cancer
- Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
Lymphoma
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003639 - Active, not recruiting
stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
- High-Dose Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
ClinicalTrials.gov Identifier: NCT00003091 - Active, not recruiting
Stage IV Melanoma; Stage IV Renal Cell Cancer; recurrent renal cell cancer; Recurrent Melanoma
- High-Dose or Low-Dose Interferon alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00002763 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Interferon alfa in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003542 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Interferon alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002869 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- Interferon alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
ClinicalTrials.gov Identifier: NCT00002892 - Active, not recruiting
stage III melanoma; Recurrent Melanoma; childhood skin cancer; stage II melanoma
- Interferon alfa Plus Radiation Therapy in Treating Patients With Stage III or Recurrent Melanoma That Has Been Removed by Surgery
ClinicalTrials.gov Identifier: NCT00005615 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Interferon alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003561 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- Interferon alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002737 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma
- Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; Quality of Life
- Interferon alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non- Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003924 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
chronic phase chronic myelogenous leukemia
- Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003451 - Active, not recruiting
Cancer
- Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00002504 - Active, not recruiting
Lymphoma; Leukemia
- Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon alfa in Treating Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00002734 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
Lymphoma; Multiple Myeloma
- A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
Hepatitis C
- Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
ClinicalTrials.gov Identifier: NCT00078442 - Active, not recruiting
HIV Infections
- STI571 Compared With Interferon alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006343 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Quality of Life
